Abstract
Insulin measurement plays a key role in the investigation of patients with hypoglycemia, subtype classification of diabetes mellitus, insulin resistance, and impaired beta cell function. However, even slight hemolysis can negatively affect insulin measurement due to RBC insulin-degrading enzyme (IDE). Here, we derived and validated an individualized correction equation in an attempt to eliminate the effects of hemolysis on insulin measurement. The effects of hemolysis on insulin measurement were studied by adding lysed self-RBCs to serum. A correction equation was derived, accounting for both percentage and exposure time of hemolysis. The performance of this individualized correction was evaluated in intentionally hemolyzed samples. Insulin concentration decreased with increasing percentage and exposure time of hemolysis. Based on the effects of hemolysis on insulin measurement of 17 donors (baseline insulin concentrations ranged from 156 to 2119 pmol/L), the individualized hemolysis correction equation was derived: INScorr = INSmeas/(0.705lgHbplasma/Hbserum − 0.001Time − 0.612). This equation can revert insulin concentrations of the intentionally hemolyzed samples to values that were statistically not different from the corresponding insulin baseline concentrations (p = 0.1564). Hemolysis could lead to a negative interference on insulin measurement; by individualized hemolysis correction equation for insulin measurement, we can correct and report reliable serum insulin results for a wide range of degrees of sample hemolysis. This correction would increase diagnostic accuracy, reduce inappropriate therapeutic decisions, and improve patient satisfaction with care.
Similar content being viewed by others
References
Gama R, Teale JD, Marks V. Best practice no 173: clinical and laboratory investigation of adult spontaneous hypoglycaemia. J Clin Pathol. 2003;56:641–6.
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline. J Clin Endocrinol Metab Endocrine Society. 2009. pp 709–28.
Chevenne D, Letailleur A, Trivin F, Porquet D. Effect of hemolysis on the concentration of insulin in serum determined by RIA and IRMA. Clin Chem. 1998;44:354–6.
Cook PR, Glenn C, Armston A. Effect of hemolysis on insulin determination by the Beckman Coulter Unicell DXI 800 immunoassay analyzer. Clinical Biochemistry. The Canadian Society of Clinical Chemists. 2010;43:621–2.
Garinet S, Fellahi S, Marlin G, Capeau J, Lefèvre G, Bastard J-P. Differential interferences of hemoglobin and hemolysis on insulin assay with the Abbott Architect®-Ci8200 immunoassay. Clinical Biochemistry The Canadian Society of Clinical Chemists. 2014;47:445–7.
O'Rahilly S, Burnett MA, Smith RF, Darley JH, Turner RC. Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia. Springer-Verlag1987;30:394–6.
Kenz El H, Bergmann P. Evaluation of immunochemiluminometric assays for the measurement of insulin and C-peptide using the ADVIA Centaur. Clin. Lab. 2004;50:171–4.
Tolan NV, Vidal-Folch N, Algeciras-Schimnich A, Singh RJ, Grebe SKG. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples. Clin Chim Acta. Elsevier B.V2013;424:216–21.
Bellomo G, Sulas MG, Mairate E, Bardone MB, Rolla R. Hemolysis is a major cause of variability in insulin measurement during oral glucose tolerance test in children. Clin Lab. 2012;58:67–74.
Sapin R, Ongagna JC, Gasser F, Grucker D. Insulin measurements in haemolysed serum: influence of insulinase inhibitors. Clin Chim Acta. 1998.
Sapin R, Ongagna JC, Gasser F, Grucker D. Insulin measurements in haemolysed serum: influence of insulinase inhibitors. Clin Chim Acta. 1998;274:111–7.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81302531), by the Natural Science Foundation of Jiangsu Province of China (BK20131018), by the Talents Planning of Six Summit Fields of Jiangsu Province (2013-WSN-037), by the National Key Clinical Department of Laboratory Medicine of China in Nanjing, by the Key laboratory for Laboratory Medicine of Jiangsu Province (XK201114), and by the Priority Academic Program Development of Jiangsu Higher Education Institutions. Special thanks to Dr. Hong Wang, Dr. Li Gao, Dr. Lixuan Liu, and Dr. Jian Liu for the measurement of hemoglobin concentration and discussion.
Author contributions
Conceived and designed the experiments: Zhi-Qi Wu and Hua-Guo Xu. Performed the experiments: Zhi-Qi Wu, Ju Lu, Huanhuan Chen and Hua-Guo Xu. Analyzed the data: Zhi-Qi Wu, Ju Lu, Huanhuan Chen, Wensen Chen and Hua-Guo Xu. Wrote the paper: Hua-Guo Xu.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the ethics committee of the First Affiliated Hospital of Nanjing Medical University. Participants provide their written informed consent to participate in this study. We have complied with the World Medical Association Declaration of Helsinki regarding ethical conduct of research involving human subjects.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Zhi-Qi Wu, Ju Lu, and Huanhuan Chen contributed equally to this work.
Rights and permissions
About this article
Cite this article
Wu, ZQ., Lu, J., Chen, H. et al. Individualized correction of insulin measurement in hemolyzed serum samples. Immunol Res 65, 605–608 (2017). https://doi.org/10.1007/s12026-016-8878-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-016-8878-7